000760276 000__ 01618cam\a2200433Ii\4500
000760276 001__ 760276
000760276 005__ 20230306142110.0
000760276 006__ m\\\\\o\\d\\\\\\\\
000760276 007__ cr\un\nnnunnun
000760276 008__ 160905s2016\\\\sz\a\\\\ob\\\\001\0\eng\d
000760276 020__ $$a9783319422237$$q(electronic book)
000760276 020__ $$a3319422235$$q(electronic book)
000760276 020__ $$z9783319422213
000760276 020__ $$z3319422219
000760276 035__ $$aSP(OCoLC)ocn957682994
000760276 035__ $$aSP(OCoLC)957682994
000760276 040__ $$aYDX$$beng$$cYDX$$dN$T$$dIDEBK$$dN$T$$dGW5XE$$dEBLCP$$dEBLB
000760276 049__ $$aISEA
000760276 050_4 $$aRC271.I45
000760276 08204 $$a616.99/406$$223
000760276 24500 $$aDefects in T cell trafficking and resistance to cancer immunotherapy$$h[electronic resource] /$$cEmmanuel Donnadieu, editor.
000760276 260__ $$aSwitzerland :$$bSpringer,$$c2016.
000760276 300__ $$a1 online resource :$$billustrations.
000760276 336__ $$atext$$btxt$$2rdacontent
000760276 337__ $$acomputer$$bc$$2rdamedia
000760276 338__ $$aonline resource$$bcr$$2rdacarrier
000760276 4901_ $$aResistance to targeted anti-cancer therapeutics.
000760276 504__ $$aIncludes bibliographical references and index.
000760276 506__ $$aAccess limited to authorized users.
000760276 650_0 $$aCancer$$xImmunotherapy.
000760276 650_0 $$aT cells$$xTherapeutic use.
000760276 650_0 $$aDrug resistance in cancer cells.
000760276 7001_ $$aDonnadieu, Emmanuel,$$eeditor.
000760276 77608 $$iPrint version:$$z9783319422213$$z3319422219$$w(OCoLC)951761660
000760276 830_0 $$aResistance to targeted anti-cancer therapeutics.
000760276 852__ $$bebk
000760276 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-42223-7$$zOnline Access$$91397441.1
000760276 909CO $$ooai:library.usi.edu:760276$$pGLOBAL_SET
000760276 980__ $$aEBOOK
000760276 980__ $$aBIB
000760276 982__ $$aEbook
000760276 983__ $$aOnline
000760276 994__ $$a92$$bISE